Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
629 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02512666 | Non Invasive Optical Imaging of WBC Count | completed | N/A | 45 | Massachusetts General HospitalOTHER | 1 | Jun 11, 2018 | clinicaltrials |
| NCT02905994 | Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia | withdrawn | Phase 1 | 0 | Massachusetts General HospitalOTHER | 1 | May 4, 2018 | clinicaltrials |
| NCT00142480 |
| Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer |
| completed |
| Phase 2 |
| 8 |
| Massachusetts General HospitalOTHER |
| 1 |
| Apr 25, 2018 |
| clinicaltrials |
| NCT01665937 | STA-9090 in Patients With Advanced Hepatocellular Cancer | completed | Phase 1 | 16 | Massachusetts General HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT01962649 | A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green | completed | Early Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT01854034 | Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR | completed | Phase 2 | 29 | Massachusetts General HospitalOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT00909948 | Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant(RLI) | terminated | Phase 1 | 7 | Massachusetts General HospitalOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT01752400 | AUY922 for Advanced ALK-positive NSCLC | completed | Phase 2 | 6 | Massachusetts General HospitalOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT01847833 | Advanced MRI Applications Development | unknown | — | — | Massachusetts General HospitalOTHER | 1 | Mar 26, 2018 | clinicaltrials |
| NCT02553538 | Improving Comprehensive Cancer Screening Among Vulnerable Patients Using Patient Navigation | completed | N/A | 1,612 | Massachusetts General HospitalOTHER | 0 | Mar 26, 2018 | clinicaltrials |
| NCT03244787 | Patient Navigation for Colorectal Cancer Screening for Patients With Mental Illness and/or Substance Use Disorder | completed | N/A | 380 | Massachusetts General HospitalOTHER | 0 | Mar 22, 2018 | clinicaltrials |
| NCT01038271 | Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) | completed | N/A | 151 | Massachusetts General HospitalOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT01396603 | Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease | completed | — | 30 | Massachusetts General HospitalOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT00113646 | Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies | terminated | Phase 2 | 14 | Massachusetts General HospitalOTHER | 1 | Mar 16, 2018 | clinicaltrials |
| NCT00113828 | Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies | terminated | Phase 2 | 5 | Massachusetts General HospitalOTHER | 1 | Mar 15, 2018 | clinicaltrials |
| NCT01074177 | Understanding Mechanisms of Acquired Resistance to BIBW2992 | completed | N/A | 24 | Massachusetts General HospitalOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT01534078 | Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma | completed | Phase 2 | 34 | Massachusetts General HospitalOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT01058239 | Bortezomib Plus Rituximab for EBV+ PTLD | completed | Phase 2 | 7 | Massachusetts General HospitalOTHER | 1 | Feb 15, 2018 | clinicaltrials |
| NCT02594696 | Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness | completed | N/A | 30 | Massachusetts General HospitalOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT01061944 | Biopsies of Cancer Patients for Tumor Molecular Characterization | completed | — | 188 | Massachusetts General HospitalOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT01400685 | Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL | completed | Phase 1 | 34 | Massachusetts General HospitalOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT02142530 | Carfilzomib Plus Belinostat in Relapsed/Refractory NHL | completed | Phase 1 | 19 | Massachusetts General HospitalOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT01188876 | Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Jan 19, 2018 | clinicaltrials |
| NCT00455897 | CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma | terminated | Phase 2 | 3 | Massachusetts General HospitalOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02705365 | Patient Navigation for Lung Screening at MGH Community Health Centers | completed | N/A | 1,200 | Massachusetts General HospitalOTHER | 1 | Jan 5, 2018 | clinicaltrials |
| NCT00438854 | Dasatinib in Relapsed Chronic Lymphocytic Leukemia | completed | Phase 2 | 15 | Massachusetts General HospitalOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT01228435 | IPI-504 in NSCLC Patients With ALK Translocations | terminated | Phase 2 | 3 | Massachusetts General HospitalOTHER | 1 | Dec 4, 2017 | clinicaltrials |
| NCT01751412 | Proton Radiation for Lymphoma Involving Mediastinum | terminated | N/A | 12 | Massachusetts General HospitalOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT01748890 | A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy | terminated | N/A | 4 | Massachusetts General HospitalOTHER | 1 | Oct 20, 2017 | clinicaltrials |
| NCT00722865 | Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma | terminated | Phase 2 | 25 | Massachusetts General HospitalOTHER | 1 | Oct 18, 2017 | clinicaltrials |
| NCT01239394 | Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma | completed | Phase 2 | 43 | Massachusetts General HospitalOTHER | 1 | Oct 18, 2017 | clinicaltrials |
| NCT01867593 | MET-PET for Newly Diagnosed Glioblastoma | completed | Early Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT01340755 | Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer | completed | N/A | 5 | Massachusetts General HospitalOTHER | 1 | Sep 6, 2017 | clinicaltrials |
| NCT00585962 | Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate | completed | Phase 2 | 57 | Massachusetts General HospitalOTHER | 1 | Sep 5, 2017 | clinicaltrials |
| NCT00483223 | Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response | completed | Phase 2 | 86 | Massachusetts General HospitalOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT01766102 | Intra-operative Digital vs. Standard Mammography | completed | Phase 4 | 72 | Massachusetts General HospitalOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT02255162 | Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML | terminated | Phase 1 | 8 | Massachusetts General HospitalOTHER | 1 | Aug 18, 2017 | clinicaltrials |
| NCT00920023 | Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI) | completed | Phase 4 | 35 | Massachusetts General HospitalOTHER | 1 | Jul 25, 2017 | clinicaltrials |
| NCT01961765 | Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia | completed | Phase 1 | 18 | Massachusetts General HospitalOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT01643668 | Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation | completed | Phase 2 | 34 | Massachusetts General HospitalOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT00694330 | Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor | completed | Phase 1 | 11 | Massachusetts General HospitalOTHER | 1 | Jun 22, 2017 | clinicaltrials |
| NCT01698710 | Endoscopic Abraxane Injection Into Pancreatic Cysts | terminated | N/A | 5 | Massachusetts General HospitalOTHER | 0 | Jun 21, 2017 | clinicaltrials |
| NCT00592748 | Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine | completed | Phase 1 / Phase 2 | 381 | Massachusetts General HospitalOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT01669148 | Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography | completed | N/A | 496 | Massachusetts General HospitalOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT02947984 | Proton/Photon Rt - Benign Meningiomas(P92-13) | completed | Phase 3 | 44 | Massachusetts General HospitalOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT00895661 | High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas | completed | Phase 2 | 40 | Massachusetts General HospitalOTHER | 1 | Jun 9, 2017 | clinicaltrials |
| NCT01927887 | Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study | completed | N/A | 12 | Massachusetts General HospitalOTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT00095836 | Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy | completed | Phase 2 | 27 | Massachusetts General HospitalOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00959985 | Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer | terminated | N/A | 23 | Massachusetts General HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00513474 | Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant | completed | Phase 1 | 46 | Massachusetts General HospitalOTHER | 1 | May 25, 2017 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials